Ignite Creation Date:
2025-12-24 @ 4:18 PM
Ignite Modification Date:
2026-04-17 @ 5:50 AM
Study NCT ID:
NCT01187966
Status:
COMPLETED
Last Update Posted:
2010-08-24
First Post:
2010-05-31
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Efficacy and Safety of Safinamide (50 and 100mg/Day) Versus Placebo, in Patients With Mid-late Stage Parkinson's Disease
Sponsor:
Newron Pharmaceuticals SPA
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
NW-1015/016/III/2006
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Dr Ravi Anand CMO
Old Organization:
Newron Pharmaceuticals